Low-dose Dexamethasone in Newly Diagnosed Pulmonary Sarcoidosis

Summary

This trial examines whether low grade suppression of the initial inflammatory process of sarcoidosis by intervention with low-dose dexamethasone therapy achieves significant alleviation of (sub-)acute symptoms, improvement in quality of life, increase in work productivity, and whether this intervention prevents disease progression and reduces total health-care costs.

Timeline

Start

2013-06

Primary completion

2016-08

Completion

—

Drugs

Indications